The novelty of nano and the regulatory challenge of newness

NanoEthics

Volumn 4, Issue 1, 2010, Pages 13-26

  Preston, Christopher J ^a   Sheinin, Maxim Y ^b   Sproat, Denyse J ^c   Swarup, Vimal P ^d  

^a UNIVERSITY OF MONTANA   (United States)

^b School of Operations Research and Industrial Engineering   (United States)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Central paradox; Emergent properties; Nanomaterial; Newness; Novelty condition; Toxic Substances Control Act

Indexed keywords

EID: 77950858959     PISSN: 18714757     EISSN: 18714765     Source Type: Journal    
DOI: 10.1007/s11569-010-0083-x     Document Type: Article

References (43)

1. American Bar Association (ABA) (2006) Regulation of nanoscale materials under the Toxic Substances Control Act. Retrieved 13th July, 2009, from http://www.abanet.org/environ/nanotech/pdf/TSCA.pdf.
2. Auffan M, Rose J, Bottero J, Lowry G, Jolivet J, Wiesner M (2009) Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nature Nanotechnology 4: 634-641.
3. British Standards Institution (2007) Guidance on the labeling of manufactured nanoparticles and products containing manufactured nanoparticles. PAS 130. Retrieved July 13th, 2009, from http://www.nanointeract.net/x/file/PAS130-labellingguidelines.pdf.
4. Buzea C, Pacheco Blandino II, Robbie K (2007) Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2: MR17-MR172.
5. Cortie MB, van der Lingen E (2002) Catalytic gold nanoparticles. Materials Forum 26: 1-14.
6. Dai HJ (2002) Carbon nanotubes: opportunities and challenges. Surface Science 500: 218-224.
7. David K, Thompson P (eds) (2008) What can nanotechnology learn from biotechnology? Societal and ethical lessons for nanoscience from the debate over agrifood biotechnology and GMO's. Elsevier, Amsterdam.
8. Davies JC (2009) Oversight of next generation nanotechnology. Washington, DC: Project on Emerging Nanotechnologies. PEN 18, April 2009. Retrieved July 22, 2009 from http://www.nanotechproject.org/publications/archive/pen18/.
9. Davies JC (2008) Nanotechnology oversight: An agenda for the next administration. Washington, DC: Project on Emerging Nanotechnologies. PEN 13, July 2008. Retrieved July 22, 2009 from http://www.nanotechproject.org/publications/archive/pen13/.
10. Davies JC (2007) EPA and Nanotechnology: Oversight for the 21st century. Washington, DC: Project on Emerging Nanotechnologies. PEN 9, May 2007. Retrieved January 21, 2010, from http://www.nanotechproject.org/process/assets/files/2698/197_nanoepa_pen 9.pdf.
11. Environmental Protection Agency (EPA) (2008) TSCA Inventory Status of Nanoscale Substances - General Approach, January 28, 2008. Retrieved July 13th, 2009, from http://www.epa.gov/oppt/nano/nmsp-inventorypaper2008.pdf.
12. Environmental Protection Agency (EPA) (2007) Nanotechnology White Paper. Retrieved 13th July, 2009 from http://www.epa.gov/osa/pdfs/nanotech/epa-nanotechnology-whitepaper-0207. pdf.
13. Environmental Protection Agency: Office of Pollution Prevention and Toxics (EPA OPPT) (2007) Overview: Office of Pollution Prevention and Toxics. Retrieved July 13th 2009, from, http://www.epa.gov/oppt/newchems/pubs/accomplishments.htm.
14. Federal Register (2008) Toxic Substances Control Act Inventory Status of Carbon Nanotubes, 73, 212, 64946-64947, October.
15. Gupta AK, Gupta M (2005) Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26: 1565-1573.
16. Gurr J-R, Wang ASS, Chen C-H, Jan K-Y (2005) Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 213: 66-73.
17. Hester RE and Harrison RM (eds) (2007) Nanotechnology: consequences for human health and environment. Issues in Environmental Science and Technology, 24. The Royal Society of Chemistry.
18. Hoet PHM, Brüske-Hohlfeld I, Salata OV (2004) Nanoparticles-known and unknown health risks. Journal of Nanobiotechnology 2: 12-27.
19. Jan E, Byrne SJ, Cuddihy M, Davies AM, Volkov Y, Gun'ko YK, Kotov NA (2008) High-content screening as a universal tool for finger printing of cytotoxicity of nanoparticles. ACS Nano 2: 928-938.
20. Kaji N, Tokeshi M, Baba Y (2007) Quantum dots for single bio-molecule imaging. Analytical Sciences 23: 21-24.
21. Klaine SJ, Alvarez PJJ, Batley GE, Fernandes TF, Handy RD, Lyon DY, Mahendra S, McLaughlin MJ, Lead JR (2008) Nanomaterials in the environment: behavior, fate, bioavailability, and effects. Environmental Toxicology and Chemistry 27: 1825-1851.
22. Kostarelos K (2008) The long and short of carbon nanotube toxicity. Nature Biotechnology 26: 774-776.
23. Lam C-W, James JT, McCluskey R, Hunter RL (2004) Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicological Sciences 77: 126-134.
24. Lam C-W, James JT, McCluskey R, Arepalli S, Hunter RL (2006) A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Critical Reviews in Toxicology 36: 189-217.
25. Lin A (2007) Size matters: regulating nanotechnology. Harvard Law Review 31: 349-408.
26. Mandel G (2008) Nanotechnology governance. Alabama Law Review 59(5): 1323-1384.
27. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444: 267-269.
28. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D (2005) Respiratory toxicity of multi-wall carbon nanotubes. Toxicology and Applied Pharmacology 207: 221-231.
29. National Nanotechnology Initiative (NNI) (2010) Retrieved January 21, 2010, from http://www.nano.gov/html/facts/faqs.html.
30. Nemmar A, Vanbilloen H, Hoylaerts MP, Hoet PHM, Verbruggen A, Nemery B (2001) Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. American Journal of Respiratory and Critical Care Medicine 164: 1665-1668.
31. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of nanomaterials at the nanolevel. Science 311: 622-627.
32. Pegg JR (2009) Congress Considers Reform of U. S. Chemicals Control Law. Environmental News Service, February 26, 2009. Retrieved July 22, 2009 from http://www.ens-newswire.com/ens/feb2009/2009-02-26-10.asp.
33. Oberdörster G (2002) Toxicokinetics and effects of fibrous and nonfibrous particles. Inhalation Toxicology 14: 29-56.
34. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives 113: 823-839.
35. Oberdörster G, Stone V, Donaldson K (2007) Toxicology of nanoparticles: A historical perspective. Nanotoxicology 1: 2-25.
36. Oldenburg SJ, Averitt RD, Westcott SL, Halas NJ (1998) Nanoengineering of optical resonances. Chemical Physics Letters 288: 243-247.
37. Powell JC (2003) A practical understanding of the polymer exemption under the Toxic Substances Control Act. Keller and Heckmann LLP. Retrieved July 13th, 2009, from http://www.khlaw.com/Files/3074_TSCA_PocketGuide_FINAL.pdf.
38. Project on Emerging Nanotechnologies (PEN) report on April 24th, 2008 Senate Science and Technology Subcommittee Hearing. Retrieved July 13th, 2009, from http://www.nanotechproject.org/news/archive/4-24-08/.
39. Rejeski D, Lekas D (2008) Nanotechnology field observations: scouting the new industrial west. Journal of Cleaner Production 16: 1014-1017.
40. Risom L, Møller P, Loft S (2005) Oxidative stress-induced DNA damage by particulate air pollution. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 592: 119-137.
41. Roduner E (2006) Size matters: why nanomaterials are different. Chemical Society Reviews 35: 583-592.
42. Taylor MR (2006) Regulating the products of nanotechnology: Does FDA have the tools it need? Washington, DC: Project on Emerging Nanotechnologies. PEN 5, October 2006. Retrieved July 22, 2009 from http://nanotechproject.org/file_download/files/PEN5_FDA.pdf.
43. Veiseh O et al (2009) Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Research 6: 6200-6207.